Skip to main content
OpenTrials
Completed

NCT Number: NCT01552395

A Study of Minirin Melt in 24 Months Treatment in Patients With Nocturia

A Confirmation of the Safety Profile for Minirin Melt in Clinical Practice

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Nemocnice Rudolfa a Stefanie (there may be other sites in this country), Benešov, Czechia

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • nocturia

Exclusion criteria

  • habitual or psychogenic polydipsia,
  • known or suspected cardiac insufficiency
  • other conditions requiring treatment with diuretics
  • moderate and severe renal insufficiency
  • known hyponatremia
  • syndrome of inappropriate ADH secretion

Treatment and study plan

Primary outcomes

  1. Number of patients with adverse events

    Time frame: 24 months

Secondary outcomes

  1. Number of changes in dosage regime

    Time frame: 24 months

Sponsors and collaborators

Lead sponsor

Ferring Pharmaceuticals

Industry

Registry information

Official study title

A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic

Important dates

Study start
2012
Primary completion
2016
Study completion
2016
First posted
Mar 13, 2012
Registry last updated
May 24, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.